ARAY peer analysis
Accuray (ARAY) against its competitors: price, today's move, 1-year return and market value side by side.
- ARAY's peers: ANIK (Anika Therapeutics), AVR (Anteris Technologies), LNSR (LENSAR), MIST (Milestone Pharmaceuticals), MXCT (MaxCyte), OWLT (Owlet), PROF (Profound Medical), RANI (Rani Therapeutics).
ARAY and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| ANIK Anika Therapeutics | $13.20 | -0.60% | 38.66% | $176.82M |
| AVR Anteris Technologies | $5.09 | 0.00% | 49.71% | $496.24M |
| LNSR LENSAR | $4.64 | -4.33% | -53.78% | $57.05M |
| MIST Milestone Pharmaceuticals | $0.40 | -13.27% | -82.86% | $49.71M |
| MXCT MaxCyte | $1.38 | 7.81% | -18.82% | $142.49M |
| OWLT Owlet | $3.23 | -11.99% | -74.06% | $96.54M |
| PROF Profound Medical | $6.38 | -3.19% | 5.11% | $233.68M |
| RANI Rani Therapeutics | $0.58 | -10.42% | -66.82% | $80.97M |
| RPID Rapid Micro Biosystems | $0.74 | -0.31% | -83.14% | $37.38M |
| TLSI TriSalus Life Sciences | $2.17 | -11.22% | -52.51% | $134.20M |
| ARAY Accuray | $2.12 | -15.20% | 129.24% | $254.74M |